Shares of AI-powered breast health solutions provider iCAD, Inc. (ICAD) rocketed over 67% on Wednesday morning after the company said it entered a definitive merger agreement with RadNet (RDNT).

Diagnostic imaging services provider RadNet (NASDAQ:RDNT), and iCAD (NASDAQ:ICAD), a provider of AI-powered breast health solutions, announced on Tuesday that they have entered into a definitive ...

iCAD (ICAD) is advancing 5% in early trading despite today’s sharp downturn of the broader market. The company, whose products utilize AI to detect breast cancer, preannounced higher-than-expected ...

ICAD ($ICAD) is expected to release its quarterly earnings data on Wednesday, March 19th after market close, per Finnhub. Analysts are expecting revenue of $4,924,050 ...

LOS ANGELES and NASHUA, N.H., April 15, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a national leader in providing high-quality, cost-effective diagnostic imaging services and ...

We recently compiled a list of the Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025. In this article, we are going to take a look at where iCAD Inc (NASDAQ:ICAD) stands against the other ...

NASHUA, N.H., March 02, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (the “Company”, NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today ...

Greetings and welcome to the iCAD Incorporated Fourth Quarter and Full Year 2023 Earnings Conference Call. At this time, all participants are on a listen-only mode, and a question-and-answer session ...

The acquisition will unite complementary leading AI-powered cancer detection and workflow solutions focused on improving the accuracy and early detection of breast cancer The transaction is expected ...

icad (NASDAQ:ICAD) just reported results for the second quarter of 2024. icad reported earnings per share of -7 cents. This met the analyst estimate for EPS of -7 cents. The company reported revenue ...